Discover 179 paid clinical trials in Mobile, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 179
FeaturedActive & Responsive
COPD, Emphysema, and Chronic Bronchitis Studies for Current or Former Smokers
for
Pulmonary Disease, Chronic Obstructive
Location: Mobile AL, Gulfport MS, Lafayette LA, Leesburg FL,
Sex: All
Age: 40 - 70+
Recruiting
Featured
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Mobile AL, Birmingham AL, Newnan GA, Memphis TN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07365241
Phase 3, Recruiting
Featured
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Mobile AL, Covington LA, New Orleans LA, Jackson MS,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06890338
Phase 2, Recruiting
Featured
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
for
Crohn's Disease
Location: Mobile AL, Dothan AL, Macon GA, Gainesville FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06548542
Phase 2, Recruiting
Featured
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Saraland AL, Ridgeland MS, Huntsville AL, Atlanta GA,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Mobile AL, Hattiesburg MS, Birmingham AL, Atlanta GA,
Sponsor: Massive Bio, Inc.
Sex: All
Age: 0+
Code: NCT03452774
Recruiting
Active & Responsive
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for
Healthy
Location: Mobile AL, Covington LA, New Orleans LA, Panama City FL,
Sponsor: Pfizer
Sex: All
Age: 0 - 49
Code: NCT07160244
Phase 3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Mobile AL, Hattiesburg MS, Athens GA, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for
Platinum-resistant Ovarian Cancer,
Location: Mobile AL, Atlanta GA, Chattanooga TN,
Sponsor: Genelux Corporation
Sex: Female
Age: 18+
Code: NCT05281471
Phase 3, Recruiting
Active & ResponsiveNew
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
for
Cutaneous Melanoma
Location: Daphne AL, Saraland AL, Mobile AL, Fairhope AL,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 70+
Code: NCT07068074
Phase 3, Recruiting
Active & Responsive
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
for
Acute Ischemic Stroke
Location: Mobile AL, New Orleans LA, Atlanta GA, Marietta GA,
Sponsor: Mercy Health Ohio
Sex: All
Age: 18 - 70+
Code: NCT05611242
Phase 3, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
for
Moderate to Severe Chronic Obstructive Pulmonary Disease
Location: Mobile AL, Dothan AL, Zachary LA, Birmingham AL,
Sponsor: Pfizer
Sex: All
Age: 35 - 70+
Code: NCT07363694
Phase 2, Phase 3, Recruiting
Active & Responsive
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
for
Coronary Artery Disease Risk Factors Multiple,
Location: Mobile AL, Birmingham AL, Hiram GA, Houston TX,
Sponsor: Duke University
Sex: All
Age: 30 - 60
Code: NCT07232069
Phase 3, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
for
Asthma
Location: Mobile AL, East Point GA, Hendersonville TN, Houston TX,
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT06977581
Phase 2, Recruiting
Active & Responsive
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
for
Tricuspid Valve Disease
Location: Mobile AL, Cincinnati OH, Indianapolis IN, Baltimore MD
Sponsor: CorMatrix Cardiovascular, Inc.
Sex: All
Age: 1 - 70+
Code: NCT02397668
Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
for
Obesity, Overweight
Location: Daphne AL, Mobile AL, Marrero LA, Baton Rouge LA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684235
Phase 3, Recruiting
Active & Responsive
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
for
Urinary Incontinence,Stress
Location: Mobile AL, Panama City FL, Birmingham AL,
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18+
Code: NCT07202884
Phase 3, Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Daphne AL, Mobile AL, Fairhope AL, Pensacola FL,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase 3, Recruiting
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity